ELTX Elicio Therapeutics, Inc.
Healthcare$9.95+0.51%ClosedMarket Cap: $189.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-126.10
P/S
0.00
EV/EBITDA
-4.88
DCF Value
$0.22
FCF Yield
-20.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-2748.2%
ROA
-177.1%
ROIC
-227.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-10.6M | $-11.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.8M | $-7.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-37.7M | $-39.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.0M | $-10.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-10.1M | $-10.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-10.7M | $-11.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-13.5M | $-14.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-45.0M | $-51.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-10.3M | $-18.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-10.9M | $-7.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-10.2M | $-11.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-9.4M | $-8.9M | $-0.93 | — |